Αποτελέσματα Αναζήτησης
SurePath™ Pap and HPV mRNA E6/E7 - Liquid-based Pap Testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Results of Cervical Cytology.
- SurePath™ Pap
SurePath™ Pap - Liquid based Pap testing is intended for use...
- SurePath™ Pap
SurePath™ Pap - Liquid based Pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda System for Reporting Results of Cervical Cytology.
Visit the Quest Diagnostics location at 99 N Brice Rd North in Columbus, OH to complete sample collection for doctor-ordered or self-purchased lab work.
SurePath™ Imaging Pap - Liquid based Pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda System for Reporting Results of Cervical Cytology.
Find a Quest Diagnostics location in Columbus, to complete sample collection for doctor-ordered or self-purchased lab tests.
Both Gynecologic and Non-Gynecologic Cytology are available from all Quest Diagnostics laboratories. For Gynecologic Cytology (Pap tests) we provide liquid-based and conventional Pap collection kits with detailed collection and submission instructions.
Helps detect disease with a more quality and easily read sample than possible with conventional Pap smears and other liquid-based cytology (LBC) tests. The BD SurePath™ test is shown to: Increase HSIL+ detection by 64.4% compared to the conventional Pap smear2